Christopher McQuinn

652 total citations · 1 hit paper
6 papers, 439 citations indexed

About

Christopher McQuinn is a scholar working on Surgery, Oncology and Immunology. According to data from OpenAlex, Christopher McQuinn has authored 6 papers receiving a total of 439 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Surgery, 3 papers in Oncology and 2 papers in Immunology. Recurrent topics in Christopher McQuinn's work include Cancer Immunotherapy and Biomarkers (3 papers), Pancreatic and Hepatic Oncology Research (2 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (1 paper). Christopher McQuinn is often cited by papers focused on Cancer Immunotherapy and Biomarkers (3 papers), Pancreatic and Hepatic Oncology Research (2 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (1 paper). Christopher McQuinn collaborates with scholars based in United States. Christopher McQuinn's co-authors include Tanios Bekaii‐Saab, Thomas A. Mace, Gregory B. Lesinski, Michael C. Ostrowski, Benjamin Swanson, Shannon Loftus, Teresa A. Zimmers, Emily Nordquist, Lianbo Yu and Thomas Ludwig and has published in prestigious journals such as Cancer Research, Gut and Journal of Vascular Surgery.

In The Last Decade

Christopher McQuinn

5 papers receiving 434 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

IL-6 and PD-L1 antibody blockade combination therapy reduces tumour progression in murine models of pancreatic cancer

2016 401 citations Thomas A. Mace, Reena Shakya et al. Gut profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Christopher McQuinn United States	3	337	187	106	62	40	6	439
Guoming Hu China	12	274 0.8×	290 1.6×	108 1.0×	58 0.9×	43 1.1×	16	505
Jean-David Fumet France	10	332 1.0×	198 1.1×	90 0.8×	57 0.9×	37 0.9×	29	460
Jinen Song China	10	222 0.7×	157 0.8×	159 1.5×	92 1.5×	37 0.9×	14	439
Changchang Lu China	9	260 0.8×	247 1.3×	131 1.2×	74 1.2×	20 0.5×	20	448
Mingxiao Lang China	7	201 0.6×	156 0.8×	129 1.2×	125 2.0×	26 0.7×	11	385
Lisa Blaydorn United States	6	290 0.9×	89 0.5×	78 0.7×	59 1.0×	29 0.7×	8	386
Maria Corallo Italy	8	300 0.9×	106 0.6×	182 1.7×	83 1.3×	25 0.6×	11	455
Perrine Garde‐Granger Canada	11	166 0.5×	117 0.6×	125 1.2×	52 0.8×	43 1.1×	12	349
Yaqun Li China	5	182 0.5×	113 0.6×	106 1.0×	36 0.6×	25 0.6×	10	320

Countries citing papers authored by Christopher McQuinn

Since Specialization

Citations

This map shows the geographic impact of Christopher McQuinn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher McQuinn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher McQuinn more than expected).

Fields of papers citing papers by Christopher McQuinn

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christopher McQuinn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher McQuinn. The network helps show where Christopher McQuinn may publish in the future.

Co-authorship network of co-authors of Christopher McQuinn

This figure shows the co-authorship network connecting the top 25 collaborators of Christopher McQuinn. A scholar is included among the top collaborators of Christopher McQuinn based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christopher McQuinn. Christopher McQuinn is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

6 of 6 papers shown

1.

Herting, Cameron J., Matthew R. Farren, Yan Tong, et al.. (2021). A multi-center, single-arm, phase Ib study of pembrolizumab (MK-3475) in combination with chemotherapy for patients with advanced colorectal cancer: HCRN GI14-186. Cancer Immunology Immunotherapy. 70(11). 3337–3348. 23 indexed citations

2.

McQuinn, Christopher, et al.. (2020). Periprocedural Hemoglobin Levels Affect Amputation Rates in Patients Undergoing Interventions for Critical Limb Ischemia. Journal of Vascular Surgery. 72(3). e300–e300. 1 indexed citations

3.

McQuinn, Christopher, Thomas A. Mace, Jacob S. Bowers, et al.. (2019). Abstract B59: IL-6 regulates CTLA4 expression on CD4+ T-cells and dual antibody blockade of IL-6 and CTLA4 leads to tumor regression in an orthotopic murine model of pancreatic ductal adenocarcinoma. Cancer Research. 79(24_Supplement). B59–B59. 1 indexed citations

4.

Latchana, Nicholas, et al.. (2017). Role of Hepatectomy for Hepatocellular Carcinoma in the Era of Transplantation and Locoregional Therapy. 1(2). 94–104.

5.

Mace, Thomas A., Reena Shakya, Jason R. Pitarresi, et al.. (2016). IL-6 and PD-L1 antibody blockade combination therapy reduces tumour progression in murine models of pancreatic cancer. Gut. 67(2). 320–332. 401 indexed citations breakdown →

6.

Ge, Striker, Enrico Lupia, Sharon J. Elliot, et al.. (1997). Glomerulosclerosis, arteriosclerosis, and vascular graft stenosis: treatment with oral heparinoids.. PubMed. 63. S120–3. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact